Coric Vlad
CIK 0001704317 Name as filed on the most recent filing
Filed as Coric Vlad (13)
44 transaction lines · from 13 filings · filed 2017-11-02 to 2026-02-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Veradermics, Inc 1 filings
- ISSUER Biohaven Ltd. 8 filings
- ISSUER Biohaven Pharmaceutical Holding Co Ltd. 4 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
44 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-05 |
Veradermics, Inc MANE |
P, Open-market purchase | 58,823 acquired | 17.00 | 999,991.00 | Form 4, filing 0001628280-26-005907 | |
| 2026-02-05 |
Veradermics, Inc MANE |
P, Open-market purchase | 58,823 acquired | 17.00 | 999,991.00 | Form 4, filing 0001628280-26-005907 | |
| 2025-11-13 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 333,333 acquired | 7.50 | 2,499,997.50 | Form 4, filing 0001704317-25-000004 | |
| 2025-11-13 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 333,333 acquired | 7.50 | 2,499,997.50 | Form 4, filing 0001704317-25-000004 | |
| 2024-10-02 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 21,052 acquired | 47.50 | 999,970.00 | Form 4, filing 0001935979-24-000077 | |
| 2024-04-22 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 121,951 acquired | 41.00 | 4,999,991.00 | Form 4, filing 0001562180-24-003493 | |
| 2023-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 113,637 acquired | 22.00 | 2,500,014.00 | Form 4, filing 0001562180-23-007246 | |
| 2023-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 340,908 acquired | 22.00 | 7,499,976.00 | Form 4, filing 0001562180-23-007246 | |
| 2022-10-31 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 25,800 acquired | 15.97 | 411,995.04 | Form 4, filing 0001562180-22-007386 | |
| 2022-10-28 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 100,000 acquired | 14.82 | 1,482,420.00 | Form 4, filing 0001562180-22-007373 | |
| 2022-10-28 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 41,930 acquired | 14.87 | 623,352.34 | Form 4, filing 0001562180-22-007373 | |
| 2022-10-25 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 853,380 acquired | 10.50 | 8,960,490.00 | Form 4, filing 0001562180-22-007332 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 80,907 acquired | 10.83 | 875,842.55 | Form 4, filing 0001562180-22-007115 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 80,606 acquired | 10.82 | 871,907.04 | Form 4, filing 0001562180-22-007115 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 73,331 acquired | 8.82 | 647,028.75 | Form 4, filing 0001562180-22-007115 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 73,005 acquired | 8.82 | 644,130.42 | Form 4, filing 0001562180-22-007115 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 54,329 acquired | 11.83 | 642,614.28 | Form 4, filing 0001562180-22-007115 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 52,523 acquired | 11.79 | 619,162.13 | Form 4, filing 0001562180-22-007115 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 34,515 acquired | 9.90 | 341,843.46 | Form 4, filing 0001562180-22-007115 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 34,459 acquired | 9.89 | 340,968.36 | Form 4, filing 0001562180-22-007115 | |
| 2022-10-05 |
Biohaven Ltd. BHVN |
P, Open-market purchase | 2,100 acquired | 12.35 | 25,928.07 | Form 4, filing 0001562180-22-007115 | |
| 2019-06-26 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
P, Open-market purchase | 5,000 acquired | 40.22 | 201,100.00 | Form 4, filing 0001209191-19-039193 | |
| 2019-03-14 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 16,110 disposed | 50.02 | 805,822.20 | Form 4, filing 0001209191-19-019521 | |
| 2019-03-14 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 15,783 disposed | 50.03 | 789,623.49 | Form 4, filing 0001209191-19-019521 | |
| 2019-03-13 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 8,262 disposed | 50.02 | 413,265.24 | Form 4, filing 0001209191-19-019521 | |
| 2019-03-13 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 7,883 disposed | 50.02 | 394,307.66 | Form 4, filing 0001209191-19-019521 | |
| 2019-03-12 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 26,007 disposed | 50.15 | 1,304,251.05 | Form 4, filing 0001209191-19-019521 | |
| 2019-03-12 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 25,955 disposed | 50.15 | 1,301,643.25 | Form 4, filing 0001209191-19-019521 | |
| 2018-06-01 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 8,611 disposed | 35.04 | 301,729.44 | Form 4, filing 0001209191-18-034777 | |
| 2018-06-01 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 5,229 disposed | 35.04 | 183,224.16 | Form 4, filing 0001209191-18-034777 | |
| 2018-05-31 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 18,971 disposed | 35.01 | 664,174.71 | Form 4, filing 0001209191-18-034777 | |
| 2018-05-31 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 15,648 disposed | 35.01 | 547,836.48 | Form 4, filing 0001209191-18-034777 | |
| 2018-05-30 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 800 disposed | 35.00 | 28,000.00 | Form 4, filing 0001209191-18-034777 | |
| 2018-05-30 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 741 disposed | 35.00 | 25,935.00 | Form 4, filing 0001209191-18-034777 | |
| 2017-11-01 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 18,074 disposed | 29.10 | 525,953.40 | Form 4, filing 0001209191-17-058948 | |
| 2017-11-01 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 18,074 disposed | 29.10 | 525,953.40 | Form 4, filing 0001209191-17-058948 | |
| 2017-11-01 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 6,926 disposed | 29.62 | 205,148.12 | Form 4, filing 0001209191-17-058948 | |
| 2017-11-01 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 6,926 disposed | 29.62 | 205,148.12 | Form 4, filing 0001209191-17-058948 | |
| 2017-10-31 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 25,828 disposed | 29.04 | 750,045.12 | Form 4, filing 0001209191-17-058948 | |
| 2017-10-31 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 25,827 disposed | 29.04 | 750,016.08 | Form 4, filing 0001209191-17-058948 | |
| 2017-10-31 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 23,123 disposed | 29.96 | 692,765.08 | Form 4, filing 0001209191-17-058948 | |
| 2017-10-31 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 23,122 disposed | 29.96 | 692,735.12 | Form 4, filing 0001209191-17-058948 | |
| 2017-10-31 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 1,050 disposed | 30.51 | 32,035.50 | Form 4, filing 0001209191-17-058948 | |
| 2017-10-31 |
Biohaven Pharmaceutical Holding Co Ltd. BHVN |
S, Open-market sale | 1,050 disposed | 30.51 | 32,035.50 | Form 4, filing 0001209191-17-058948 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 22
- Open-market sale 22
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Coric Vlad, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001704317
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6